Clinical Trial Detail

NCT ID NCT01769391
Title A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

lung non-small cell carcinoma

Therapies

Necitumumab

Carboplatin + Paclitaxel

Age Groups: adult

No variant requirements are available.